Dibenzylpiperazine

Dibenzylpiperazine
Names
Preferred IUPAC name
1,4-Dibenzylpiperazine
Other names
DBZP
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.153.085 Edit this at Wikidata
UNII
  • InChI=1S/C18H22N2/c1-3-7-17(8-4-1)15-19-11-13-20(14-12-19)16-18-9-5-2-6-10-18/h1-10H,11-16H2 ☒N
    Key: YPUGLZQRXQQCSX-UHFFFAOYSA-N ☒N
  • InChI=1/C18H22N2/c1-3-7-17(8-4-1)15-19-11-13-20(14-12-19)16-18-9-5-2-6-10-18/h1-10H,11-16H2
    Key: YPUGLZQRXQQCSX-UHFFFAOYAP
  • C1CN(CCN1CC2=CC=CC=C2)CC3=CC=CC=C3
  • c1ccc(cc1)CN2CCN(CC2)Cc3ccccc3
Properties
C18H22N2
Molar mass 266.388 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Dibenzylpiperazine (DBZP) is a piperazine derivative often found as an impurity in the recreational stimulant drug benzylpiperazine (BZP).[1] Presence of DBZP is a marker for low quality or badly made BZP. It can be made as a reaction byproduct during BZP synthesis, either because the reaction has been run at too high a temperature, or because an excess of benzyl chloride has been used.

Pharmacology and effects

[edit]

It is not known to have any stimulant effects in its own right, although this has not been tested.

Toxicity

[edit]

The toxicity of DBZP is unknown.

[edit]

China

[edit]

As of October 2015 DBZP is a controlled substance in China.[2]

United States

[edit]

DBZP is not scheduled as a controlled substance at the federal level in the United States.[3] It is possible that it could be considered an analog BZP, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.

Florida

[edit]

DBZP is a Schedule I controlled substance in the state of Florida making it illegal to buy, sell, or possess in Florida.[4]

See also

[edit]

References

[edit]
  1. ^ Davies S, Wood DM, Smith G, Button J, Ramsey J, Archer R, et al. (July 2010). "Purchasing 'legal highs' on the Internet--is there consistency in what you get?". QJM. 103 (7): 489–93. doi:10.1093/qjmed/hcq056. PMID 20413562.
  2. ^ "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Archived from the original on 1 October 2015. Retrieved 1 October 2015.
  3. ^ "21 CFR — Schedules of Controlled Substances §1308.11 Schedule I." Archived from the original on 2009-08-27. Retrieved 2014-12-17.
  4. ^ "Florida Statutes - Chapter 893 - Drug Abuse Prevention and Control".